Thursday, October 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

TKMS: Record Order Book and a Finished Submarine Chapter, Yet the Share Price Keeps Drifting Lower

Kennethcix by Kennethcix
September 6, 2026
in Analysis, Defense & Aerospace, Earnings
0
TKMS Stock
0
SHARES
44
VIEWS
Share on FacebookShare on Twitter

The handover of the INS Drakon to the Israeli Navy closed out one of TKMS’s most storied production runs, but the milestone did little to shift the mood in the trading room. Shares settled at EUR 83.30 on Friday, down 0.5 percent on the day, extending a slide that has now reached 7.6 percent over the past seven sessions and 5.7 percent over the last month. The stock remains roughly 23 percent below its August peak of EUR 108.80, a gap that looks all the more striking given the strength of the underlying business.

The disconnect is not hard to quantify. For the first nine months of fiscal 2025/26, revenue climbed 19 percent year on year to EUR 1.890 billion, up from EUR 1.587 billion in the prior-year period. Adjusted EBIT rose 13 percent to EUR 110 million, propelled by the Submarines segment, where the metric nearly tripled. The order backlog stands at EUR 20.1 billion, providing revenue visibility that most industrial companies can only envy.

That performance prompted management to tear up its earlier guidance. Where the company had previously braced for a 1 to 2 percent decline in sales, it now expects growth of 10 to 12 percent, with the adjusted EBIT margin reaching as high as 6.5 percent. For a defence contractor accustomed to decade-long programme cycles, the speed of the revision signals that the order book is being worked through faster than anticipated.

The delivery of the Drakon, the third and final boat in the Dolphin-AIP class, fits neatly into that narrative of execution reliability. Completing a complex, multi-year submarine programme on schedule is precisely the kind of reference point that matters when a shipyard is juggling multiple frigate and submarine contracts simultaneously. Yet the market’s reaction suggests that operational competence alone is no longer enough to move the needle.

Should investors sell immediately? Or is it worth buying TKMS?

Part of the caution can be traced to the F127 frigate programme. Reporting in Der Spiegel at the end of August put the cost estimate for the eight planned vessels at over EUR 40 billion, a sharp jump from the roughly EUR 26 billion figure previously cited. TKMS rejected the number outright, arguing it was not traceable and did not reflect the agreed cost-sharing arrangement with partner Rheinmetall. Even so, the gap between media portrayals and the company’s own account has a habit of unsettling investors, regardless of whether the operational foundation remains intact.

The decision in July to withdraw the non-binding takeover offer for German Naval Yards Kiel adds another layer of nuance. TKMS cited the failure to reach agreement with owner CMN Naval on economic terms, while insisting that its existing yards in Kiel and Wismar are sufficient for current and future workloads. The retreat signals a degree of capital allocation discipline that sits oddly alongside the company’s operational expansion — but it also suggests management is unwilling to overpay for capacity it may not need.

The Fincantieri memorandum of understanding, deepened last Thursday, points in a different direction. Both shipyards were at pains to stress that the arrangement is neither a merger nor an acquisition, and that national programmes will continue unchanged. A binding collaboration framework covering the submarine and underwater domain is expected by year-end. Israeli sources have floated the idea of joint resilience projects with Germany, though that appears to be an announcement on the Israeli side rather than a TKMS statement.

No fresh financial details accompanied either the Dolphin handover or the Fincantieri MoU. The most recent price target circulating in the market, around EUR 111, stems from an older survey and should not be read as a current assessment. That leaves investors with a curious situation: a company that has just raised its outlook, delivered a flagship submarine programme and deepened a European partnership — yet whose share price cannot seem to hold its ground. The market’s focus, for now, remains fixed on the F127 cost question and the Kiel retreat, while the positive news flow is treated as already priced in. Whether the Fincantieri framework agreement, once finalised, can shift that dynamic is the open question for the months ahead.

Ad

TKMS Stock: Buy or Sell?! New TKMS Analysis from October 22 delivers the answer:

The latest TKMS figures speak for themselves: Urgent action needed for TKMS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.

TKMS: Buy or sell? Read more here...

Tags: TKMS
Kennethcix

Kennethcix

Related Posts

Rheinmetall Stock
DAX

Rheinmetall’s Order Book Pushes Past €80 Billion as New Shell Deal Lands

September 14, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
TKMS Stock
Defense & Aerospace

TKMS Closes the Dolphin Chapter and Courts Fincantieri — But Shareholders Are Still Waiting for the Tide to Turn

September 7, 2026
Next Post
Amphenol Stock

Amphenol's Post-Split Reality Check: The Order Book, Not the Mechanics, Is the Story

Take-Two Interactive Stock

Take-Two's Blockbuster Buzz Meets a Stock That Refuses to Play Along

Deutz Stock

Deutz's Two-Front Advance: An Indian Engine Pact Arrives as the FFG Takeover Nears Completion

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com